Get ready for ‘little pink pill’ ads

Sponsorship

Mark Matassa Jan 12, 2018

Jan 12, 2018

Republish Article

You can republish articles in print or online. Simply copy the HTML below, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, and credit to Cascade PBS. Republishing of the photos or videos embedded in an article can occur only if the photo or video is a copyright of Cascade Public Media ("CPM") and not of a third party. Photos and videos that are a copyright of CPM are not required to appear in the republished article, but if they are used, they must be embedded where they appear in the original article and must include the attribution to the CPM photographer.

You may reprint in any medium
You may edit only for tense and timeliness
If republishing in print you can edit for length if you follow our print republishing guidelines.
You may write your own headline
Include a byline and shirttail with credit and link to Cascade PBS
Include our tracking pixel
Remove if we ask

          <article>
            <header>
              <hgroup>
                <h1>Get ready for ‘little pink pill’ ads</h1>
                <h2><p>The FDA this week approved a libido pill for women that, despite the inviting comparisons to Viagra, is really a different thing. Unlike the little blue pill for men, which treats erectile dysfunction, the new Addyi is described by The New York Times as the first drug approved to treat</p></h2>
              </hgroup>
               <p>By <a href="/author/mmatassa-mac-com/">Mark Matassa</a></p> 
              <p><time datetime="2025-02-04T05:00:00-08:00">Jan 12, 2018</time></p>
            </header>
            <figure class="kg-card kg-image-card"><img src="https://dev.cascadepbs.org/content/images/sites/default/files/images/article/gallery/sprout-pill_custom-1dd00605e426667707a9810b71fde0464a65a194-s700-c85.jpg" class="kg-image" alt="Credit:" loading="lazy" width="300" height="186"></figure><p>The FDA this week approved a libido pill for women that, despite the inviting comparisons to Viagra, is really a different thing. Unlike the little blue pill for men, which treats erectile dysfunction, the new Addyi is described by <em>The New York Times</em> as the <a href="http://www.nytimes.com/2015/08/19/business/fda-approval-addyi-female-viagra.html?hpw=&rref=health&action=click&pgtype=Homepage&module=well-region&region=bottom-well&WT.nav=bottom-well&ref=dev.cascadepbs.org">first drug approved</a> to treat a flagging libido for either gender. In the future will anyone do it the old-fashioned way, with cocktails instead of pills?</p>
          </article>

The FDA this week approved a libido pill for women that, despite the inviting comparisons to Viagra, is really a different thing. Unlike the little blue pill for men, which treats erectile dysfunction, the new Addyi is described by The New York Times as the first drug approved to treat a flagging libido for either gender. In the future will anyone do it the old-fashioned way, with cocktails instead of pills?

Get ready for ‘little pink pill’ ads

Republish Article

By Mark Matassa